| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acidification of α-granules in megakaryocytes by vacuolar-type adenosine triphosphatase is essential for organelle biogenesis
|
Lu, Chien-Yi
|
|
|
22 |
8 |
p. 2294-2305
|
artikel
|
| 2 |
Annoucements
|
|
|
|
22 |
8 |
p. 2380
|
artikel
|
| 3 |
“Antiphospholipid antibody solid phase–based assays: problems and proposed solutions for the 2023 ACR/EULAR classification criteria for antiphospholipid syndrome”: reply
|
Huisman, Albert
|
|
|
22 |
8 |
p. 2373-2374
|
artikel
|
| 4 |
“Antiphospholipid antibody solid phase–based assays: problems and proposed solutions for the 2023 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for antiphospholipid syndrome”: comment
|
Tripodi, Armando
|
|
|
22 |
8 |
p. 2371-2372
|
artikel
|
| 5 |
Application of genetic testing for the diagnosis of von Willebrand disease
|
Seidizadeh, Omid
|
|
|
22 |
8 |
p. 2115-2128
|
artikel
|
| 6 |
Clinical outcomes after discontinuing anticoagulant therapy in patients with first unprovoked venous thromboembolism
|
Gabara, Cristina
|
|
|
22 |
8 |
p. 2234-2246
|
artikel
|
| 7 |
Comprehensive functional characterization of a novel ANO6 variant in a new patient with Scott syndrome
|
Montague, Samantha J.
|
|
|
22 |
8 |
p. 2281-2293
|
artikel
|
| 8 |
Corrigendum to ‘Trivalent nanobody-based ligands mediate powerful activation of GPVI, CLEC-2 and PEAR1 in human platelets whereas FcγRIIA requires a tetravalent ligand’
|
Martin, Eleyna M.
|
|
|
22 |
8 |
p. 2378-2379
|
artikel
|
| 9 |
Development of endothelial-targeted CD39 as a therapy for ischemic stroke
|
Lee, Natasha Ting
|
|
|
22 |
8 |
p. 2331-2344
|
artikel
|
| 10 |
Diagnosis of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: data from a practice-based longitudinal cohort
|
Hobohm, Lukas
|
|
|
22 |
8 |
p. 2203-2210
|
artikel
|
| 11 |
Dilemmas in the diagnosis and management of antiphospholipid syndrome
|
Manning, James E.
|
|
|
22 |
8 |
p. 2156-2170
|
artikel
|
| 12 |
DNA base editing corrects common hemophilia A mutations and restores factor VIII expression in in vitro and ex vivo models
|
Tonetto, Elena
|
|
|
22 |
8 |
p. 2171-2183
|
artikel
|
| 13 |
Extracorporeal membrane oxygenation aggravates platelet glycoprotein V shedding and δ-granule deficiency in COVID-19–associated acute respiratory distress syndrome
|
Herrmann, Johannes
|
|
|
22 |
8 |
p. 2316-2330
|
artikel
|
| 14 |
Fibrinogen binding to histones in circulation protects against adverse cellular and clinical outcomes
|
Toh, Julien M.
|
|
|
22 |
8 |
p. 2247-2260
|
artikel
|
| 15 |
Genome-wide investigation of exogenous female hormones, genetic variation, and venous thromboembolism risk
|
Hasser, Emily K.
|
|
|
22 |
8 |
p. 2261-2269
|
artikel
|
| 16 |
Hormonal contraceptive use after a first venous thrombotic event and the risk of recurrence in premenopausal women
|
Verlaan, Judith P.L.
|
|
|
22 |
8 |
p. 2195-2202
|
artikel
|
| 17 |
Issue Information
|
|
|
|
22 |
8 |
p. e1-e5
|
artikel
|
| 18 |
Met343Val mutation disrupts the shuttling of Trp380 leading to a low-activity conformer of activated protein C and causes thrombosis
|
Zhou, Shijie
|
|
|
22 |
8 |
p. 2270-2280
|
artikel
|
| 19 |
Mimicking activated protein C-progress by PARtnering peptides
|
Fleming, Harry
|
|
|
22 |
8 |
p. 2153-2155
|
artikel
|
| 20 |
Minimally modified human blood coagulation factor X to bypass direct factor Xa inhibitors
|
Schreuder, Mark
|
|
|
22 |
8 |
p. 2211-2226
|
artikel
|
| 21 |
Obituary Professor Margareta “Meta” Blombäck (1925-2024)
|
Antovic, Jovan P.
|
|
|
22 |
8 |
p. 2375-2377
|
artikel
|
| 22 |
Perioperative management and outcomes in patients receiving low-dose rivaroxaban and/or aspirin: a subanalysis of the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) trial
|
Douketis, James D.
|
|
|
22 |
8 |
p. 2227-2233
|
artikel
|
| 23 |
“Prothrombin conversion and thrombin decay in patients with cirrhosis—role of prothrombin and antithrombin deficiencies”: comment
|
Sinegre, Thomas
|
|
|
22 |
8 |
p. 2366-2370
|
artikel
|
| 24 |
“Prothrombin conversion and thrombin decay in patients with cirrhosis—role of prothrombin and antithrombin deficiencies”: comment from de Laat-Kremers et al.
|
de Laat-Kremers, Romy
|
|
|
22 |
8 |
p. 2363-2365
|
artikel
|
| 25 |
RNA therapeutics to control fibrinolysis: review on applications in biology and medicine
|
Ferraresso, Francesca
|
|
|
22 |
8 |
p. 2103-2114
|
artikel
|
| 26 |
The convergent model of coagulation
|
Yong, Jun
|
|
|
22 |
8 |
p. 2140-2146
|
artikel
|
| 27 |
The historical origins of modern international normalized ratio targets
|
Raza, Sheharyar
|
|
|
22 |
8 |
p. 2184-2194
|
artikel
|
| 28 |
The use of 1E12, a monoclonal anti-platelet factor 4 antibody, to improve the diagnosis of vaccine-induced immune thrombotic thrombocytopenia
|
Vayne, Caroline
|
|
|
22 |
8 |
p. 2306-2315
|
artikel
|
| 29 |
Thrombotic risk associated with gender-affirming hormone therapy
|
Mullins, Tanya L. Kowalczyk
|
|
|
22 |
8 |
p. 2129-2139
|
artikel
|
| 30 |
Toward harmonized interpretation of anticardiolipin and anti–β2-glycoprotein I antibody detection for diagnosis of antiphospholipid syndrome using defined level intervals and likelihood ratios: communication from the ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies
|
Vandevelde, Arne
|
|
|
22 |
8 |
p. 2345-2362
|
artikel
|
| 31 |
Unexpected bleeding with platelet phosphatidylserine exposure defect: new kindred motivates rethinking Scott syndrome
|
Gilbert, Gary E.
|
|
|
22 |
8 |
p. 2147-2149
|
artikel
|
| 32 |
Venous thromboembolism and estrogen—dance with the devil in thrombosis medicine
|
Vrotniakaite-Bajerciene, Kristina
|
|
|
22 |
8 |
p. 2150-2152
|
artikel
|
Tijdschrift beschrijving